According to a new study, however, that may be changing. The team of researchers in China came up with a treatment that used ...

Chinese scientists have achieved a world-first by successfully treating a 25-year-old woman with type 1 diabetes using a stem ...

Type 1 diabetes in China has successfully undergone a stem-cell therapy that enabled her to produce her own insulin, reducing ...

KYOTO--Kyoto University Hospital next February will start a clinical trial to develop an easier treatment for intractable type 1 diabetes ... pluripotent stem (iPS) cells. The medical center ...

Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced ...

Limbal stem cell deficiency is a pathologic condition that occurs when the eye's surface cells are damaged and cannot regenerate the surface of the cornea, leading to scarring and ultimately blindness ...

These symptoms stem from the body’s inability to properly regulate blood sugar. In Type 1 diabetes, the pancreas stops ...

These jabs work by providing an instruction to the patient’s cells to churn out a particular protein that acts as a flag for ...

Early research shows the CD40L antibody tegoprubart is able to reduce insulin dependence in patients with type 1 diabetes after islet transplants.